For the year ending 2025-12-31, MAIA has $9,704,656 in assets. $7,328,793 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 8,658,031 | |||
| Prepaid expenses and other current assets | 1,043,825 | |||
| Total current assets | 9,701,856 | |||
| Other assets | 2,800 | |||
| Total assets | 9,704,656 | |||
| Accounts payable | 2,038,803 | |||
| Accrued expenses | 3,797,595 | |||
| Total current liabilities | 5,836,398 | |||
| Warrant liability | 1,492,395 | |||
| Total liabilities | 7,328,793 | |||
| Common stock, 0.0001 par value, 150,000,000 and 70,000,000 shares authorized at december 31, 2025 and december 31, 2024, 38,624,289 and 26,157,788 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 3,863 | |||
| Additional paid-in capital | 112,053,233 | |||
| Accumulated deficit | -109,631,005 | |||
| Accumulated other comprehensive loss | -50,228 | |||
| Total stockholders equity | 2,375,863 | |||
| Total liabilities and stockholders equity | 9,704,656 | |||
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)